NCT00189748View on ClinicalTrials.gov

A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2004

Conditions
Bone Marrow TransplantationGraft Versus Host DiseaseGraft-Versus-Host DiseaseGraft-Vs-Host Disease
Interventions
DRUG

Tacrolimus

Trial Locations (4)

Unknown

Chubu Region

Hokkaido Region

Kanto Region

Kyusyu Region

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00189748 - A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension- | Biotech Hunter | Biotech Hunter